ABC UK Improving Outcomes for Patients Programme 2021 & 2022

ABC UK IOPP 2021 Grants

The 2021 round of ABC UK's IOPP grants programme opened for applications in November 2021 and closed in March 2022.

The previous rounds of IOPP had been heavily impacted by COVID-19.  However, we were delighted that (with flexibility on project completion dates) the 2020 grants did produce some extremely valuable and interesting work.

The 2021 IOPP round launched in the Autumn of 2021 - when the on-going impact of COVID-19 on NHS Trusts and staff, and on other clinical and research settings were still being felt.  Again, ABC UK is delighted with the response, particularly in these circumstances, and pleased again to be able to fund valuable, and unique, research into bladder cancer.

GRANTS WERE AWARDED TO THE FOLLOWING PROJECTS 


Anna Haire and Mieke Van Hemelrijck - Kings College London

Project Title:  Understanding the barriers and facilitators to patients accepting a novel diagnostic technique replacing the Gold Standard


Professor Hardev Pandha, Dr Nicola Annels - University of Surrey

Project Title:  Assessing the efficacy of oncolytic immunotherapy for non-muscle invasive bladder cancer (NMIBC) using Nanostring technology


Dr Sapna Lunj (Postdoctoral research associate), Professor Ananya Choudhury - University of Manchester

Project Title:  Identification of transmembrane proteins as therapeutic targets for hypoxia in muscle invasive bladder cancer 


A further project was awarded a grant, however the project start date has been amended - further information to follow.

 

How we help you

Latest News / Events

Muscle invasive bladder cancer - challenges around the pathway of care webinar - 15th July 2024 04/06/2024

Muscle invasive bladder cancer - challenges around the pathway of care A Nurses' Bladder Cancer Education Webinar This webinar will be presented by Helen Johnson who is a urology oncology clinical nurse specialist at the Christie Hospital in Manchester. She has been a CNS for ...

News & Events
Read more

We're on Twitter

Facebook